Mohamed M S, Mukherjee M, Kakkar V V
Thrombosis Research Institute, London, UK.
J R Coll Surg Edinb. 1998 Jun;43(3):155-7.
The effect on graft thrombogenicity of binding heparin to the luminal surface of prosthetic arterial grafts was investigated. Venous blood was obtained from healthy volunteers and exposed for 30 minutes to tubular segments of standard knitted dacron, polytetrafluoroethylene (PTFE) and a recently introduced heparin-bound knitted dacron graft. After this exposure the fibrinogen level of each sample was measured. The median (range) fibrinogen levels (expressed as a percentage of that in unexposed blood samples) were: standard dacron 3.5% (0-5.4%); PTFE 95.5% (0-121.1%); and heparin-bound dacron 79.8% (3.8-109.6%). Fibrinogen levels in the standard dacron group were significantly less than that of the PTFE and heparin-bound dacron groups (P < 0.05). No significant difference was found between the fibrinogen levels of the PTFE and heparin-bound dacron groups (P = 0.35). These findings suggest that heparin binding significantly reduces fibrinogen consumption and hence may reduce graft thrombogenicity.
研究了肝素与人工动脉移植物管腔表面结合对移植物血栓形成性的影响。从健康志愿者获取静脉血,并将其暴露于标准针织涤纶、聚四氟乙烯(PTFE)和最近推出的肝素结合针织涤纶移植物的管状节段30分钟。暴露后,测量每个样本的纤维蛋白原水平。中位数(范围)纤维蛋白原水平(表示为未暴露血样中纤维蛋白原水平的百分比)为:标准涤纶3.5%(0 - 5.4%);PTFE 95.5%(0 - 121.1%);肝素结合涤纶79.8%(3.8 - 109.6%)。标准涤纶组的纤维蛋白原水平显著低于PTFE组和肝素结合涤纶组(P < 0.05)。PTFE组和肝素结合涤纶组的纤维蛋白原水平之间未发现显著差异(P = 0.35)。这些发现表明,肝素结合可显著减少纤维蛋白原消耗,因此可能降低移植物血栓形成性。